glycosaminoglycans
Showing 1 - 25 of 131
Respiratory Cathepsins, Proteases Inhibitors and
Completed
- Mucopolysaccharidoses
- Sputum
- Tracheal aspiration
-
Angers, France
- +6 more
Jan 3, 2022
AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication
Recruiting
- Muscle-Invasive Bladder Carcinoma
- GAG score
-
Roskilde, Denmark
- +2 more
Jun 21, 2022
Mucopolysaccharidosis II Trial (Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII)
Not yet recruiting
- Mucopolysaccharidosis II
- Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
- (no location specified)
Dec 16, 2022
Mucopolysaccharidosis Type II Natural History
Completed
- Mucopolysaccharidosis II
-
Pittsburgh, Pennsylvania
- +2 more
Apr 22, 2022
MPS I Trial in Oakland (SB-318)
Terminated
- MPS I
- SB-318
-
Oakland, CaliforniaUCSF Benioff Children's Hospital Oakland
Jan 6, 2023
MPS IIIA, Sanfilippo Syndrome, Sanfilippo A Trial in Australia, Spain, United States (ABO-102)
Active, not recruiting
- MPS IIIA
- +3 more
- ABO-102
-
Columbus, Ohio
- +4 more
Nov 8, 2022
Chronic Heart Failure Trial in Amsterdam (Endocalyx Pro, )
Recruiting
- Chronic Heart Failure
- Endocalyx Pro
- placebo
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC
Jul 21, 2023
MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)
Not yet recruiting
- MPS-IH (Hurler Syndrome)
- Experimental: OTL-203
- Active Comparator: Allo-HSCT
-
Oakland, California
- +6 more
Nov 27, 2023
Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome Trial in Rome (Aldurazyme (laronidase))
Recruiting
- Mucopolysaccharidosis I
- +3 more
- Aldurazyme (laronidase)
-
Rome, ItalyDipartimento di Scienze Pediatriche Medico - Chirurgiche e Neuro
Mar 28, 2022
Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)
Recruiting
- Mucopolysaccharidosis I
- +7 more
- There is no intervention
-
San Francisco, CaliforniaUniversity of California San Francisco
Nov 9, 2022
LEVANTIS-0093A: GAGomes for Multi-Cancer Early Detection in
Recruiting
- Cancer
-
Leeds, United KingdomLeads Teaching Hospitals Trust
Mar 15, 2022
Hypertension Trial in Cambridge, London (Amlodipine, Chlortalidone)
Not yet recruiting
- Hypertension
-
Cambridge, United Kingdom
- +1 more
Jul 27, 2023
MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))
Withdrawn
- MPS I
- +2 more
- SIG-005 (hIDUA Producing Spheres)
-
Porto Alegre, Brazil
- +2 more
Dec 16, 2022
MPS IVA, MPS VI Trial in Oakland (Vosoritide Injection [Voxzogo])
Not yet recruiting
- MPS IVA
- MPS VI
- Vosoritide Injection [Voxzogo]
-
Oakland, CaliforniaUCSF Benioff Children's Hospital Oakland
May 4, 2023
Iris Cameras in Mucopolysaccharidoses
Not yet recruiting
- Mucopolysaccharidoses
- Imaging
-
Manchester, United KingdomManchester University NHS Foundation Trust
Aug 30, 2022
Burns Trial in Aurora (Fresh Frozen Plasma)
Recruiting
- Burns
- Fresh Frozen Plasma
-
Aurora, ColoradoUniversity of Colorado Denver Anschutz Medical Campus
Feb 22, 2022
Mucopolysaccharidosis Type I (MPS I), Hurler Syndrome, Hurler-Scheie Syndrome Trial in Orange, Philadelphia, Porto Alegre
Active, not recruiting
- Mucopolysaccharidosis Type I (MPS I)
- +2 more
- RGX-111
-
Orange, California
- +3 more
Jan 9, 2023
Mucopolysaccharidosis II, MPS II Trial in United States (SB-913)
Terminated
- Mucopolysaccharidosis II
- MPS II
- SB-913
-
Oakland, California
- +4 more
Oct 21, 2022
Mucopolysaccharidosis Type IIIA Trial in Manchester (Autologous CD34+ cells transduced with a lentiviral vector containing the
Active, not recruiting
- Mucopolysaccharidosis Type IIIA
- Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene
-
Manchester, United KingdomManchester University NHS Foundation Trust
Jul 2, 2021
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023
Rhytides Trial in San Francisco (AmnioFix plus Standard of Care, Standard of Care)
Withdrawn
- Rhytides
- AmnioFix plus Standard of Care
- Standard of Care
-
San Francisco, CaliforniaUCSF Dermatology
Mar 7, 2022
Water and Electrolytes Content in HYpertension (WHYSKI) in SKIn
Recruiting
- Hyperaldosteronism
- +7 more
- Skin Biopsy
- Video-laparoscopic adrenalectomy
-
Padova, ItalyAzienda Ospedale Università di Padova
Oct 23, 2023
LEVANTIS-0087A: GAGomes for Multi-Cancer Early Detection in
Recruiting
- Cancer
- Combined free GAGome MCED test
-
Stockholm, SwedenElypta AB
Mar 29, 2022
Hunter Syndrome Trial in Lexington
Recruiting
- Hunter Syndrome
-
Lexington, MassachusettsShire
Nov 7, 2022